Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above
Clinical trial NCT00319098 · COMPLETED
Trial details
- NCT number
- NCT00319098
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-01-01
- Enrollment
- 5075
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.